Financial statements Bioestry
Cash flow statement of Bioestry
Company age:
Age:
19 y. 9 m. 14 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of BIOESTRY
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 6 033 570,58 | 3 602 978,10 | 3 440 862,56 | 4 157 087,07 | 2 260 849,74 | 2 447 856,56 |
| Net cash flow from investing activities | -322 230,98 | -302 927,55 | -192 078,56 | -337 875,60 | -129 747,01 | -86 323,79 |
| Net cash flow from financial activities | -5 445 755,76 | -3 479 806,13 | -1 969 697,40 | -4 153 423,81 | -1 389 117,91 | -1 126 303,17 |
| Total net cash flow | 265 583,84 | -179 755,58 | 1 279 086,60 | -334 212,34 | 741 984,82 | 1 235 229,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.